TENX
Tenax Therapeutics Inc
NASDAQ: TENX · HEALTHCARE · BIOTECHNOLOGY
$13.11
+2.58% today
Updated 2026-04-30
Market cap
$376.32M
P/E ratio
—
P/S ratio
414.72x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$5 – $18
Volume
0.5M
Tenax Therapeutics Inc (TENX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-55.60%
ROA
-35.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $-25633.00 | $-3.33M | 100.00% | 9,669.53% | 12,994.46% |
| 2007 | $-24131.00 | $-3.33M | 100.00% | 7,344.95% | 13,803.28% |
| 2008 | — | $-6.72M | — | — | — |
| 2009 | $47386.00 | $-10.51M | 17.63% | -21,528.50% | -22,174.01% |
| 2010 | $322349.00 | $-10.45M | -64.48% | -3,276.78% | -3,241.30% |
| 2011 | $415034.00 | $-15.71M | 87.65% | -1,980.61% | -3,785.81% |
| 2012 | $288726.00 | $-19.54M | 55.04% | -5,844.34% | -6,768.30% |
| 2013 | $288726.00 | $-19.54M | 55.04% | -5,753.25% | -6,768.30% |
| 2014 | $49286.00 | $-14.08M | 100.00% | -27,775.19% | -28,571.63% |
| 2015 | $49286.00 | $-14.08M | 80.26% | -31,729.59% | -28,571.63% |
| 2016 | $0.00 | $-43.92M | — | — | — |
| 2017 | $0.00 | $-8.84M | — | — | — |
| 2018 | $0.00 | $-6.81M | — | — | — |
| 2019 | $0.00 | $-8.39M | — | — | — |
| 2020 | $0.00 | $-9.85M | — | — | — |
| 2021 | $0.00 | $-32.47M | — | — | — |
| 2022 | $0.00 | $-11.05M | — | — | — |
| 2023 | $0.00 | $-7.71M | — | — | — |
| 2024 | $0.00 | $-17.60M | — | — | — |
| 2025 | $0.00 | $-52.60M | — | — | — |